Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Neurology

Journal Scan / Research · June 05, 2019

Direct Oral Anticoagulants Are Safer Than Vitamin K Antagonists in Ischemic Stroke Patients With Atrial Fibrillation

Annals of Neurology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Annals of Neurology
Direct Oral Anticoagulants Versus Vitamin K Antagonists After Recent Ischemic Stroke in Patients With Atrial Fibrillation
Ann. Neurol 2019 Jun 01;85(6)823-834, DJ Seiffge, M Paciaroni, D Wilson, M Koga, K Macha, M Cappellari, S Schaedelin, C Shakeshaft, M Takagi, G Tsivgoulis, B Bonetti, B Kallmünzer, S Arihiro, A Alberti, AA Polymeris, G Ambler, S Yoshimura, M Venti, LH Bonati, KW Muir, H Yamagami, S Thilemann, R Altavilla, N Peters, M Inoue, T Bobinger, G Agnelli, MM Brown, S Sato, M Acciarresi, HR Jager, P Bovi, S Schwab, P Lyrer, V Caso, K Toyoda, DJ Werring, ST Engelter, GM De Marchis,

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading